{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:34:33Z","timestamp":1784309673730,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2017\/322"],"award-info":[{"award-number":["CAN 2017\/322"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006636","name":"Forskningsr\u00e5det om H\u00e4lsa, Arbetsliv och V\u00e4lf\u00e4rd","doi-asserted-by":"publisher","award":["2017-00531"],"award-info":[{"award-number":["2017-00531"]}],"id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201806240005"],"award-info":[{"award-number":["201806240005"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1147498"],"award-info":[{"award-number":["GNT1147498"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["IIRS-20 to 025"],"award-info":[{"award-number":["IIRS-20 to 025"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["PF-15 to 014"],"award-info":[{"award-number":["PF-15 to 014"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cancer patients have a highly increased risk of psychiatric disorders following diagnosis, compared with cancer-free individuals. Inflammation is involved in the development of both cancer and psychiatric disorders. The role of non-steroidal anti-inflammatory drugs (NSAIDs) in the subsequent risk of psychiatric disorders after cancer diagnosis is however unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a cohort study of all patients diagnosed with a first primary malignancy between July 2006 and December 2013 in Sweden. Cox proportional hazards models were used to assess the association of NSAID use during the year before cancer diagnosis with the risk of depression, anxiety, and stress-related disorders during the first year after cancer diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 316,904 patients identified, 5613 patients received a diagnosis of depression, anxiety, or stress-related disorders during the year after cancer diagnosis. Compared with no use of NSAIDs, the use of aspirin alone was associated with a lower rate of depression, anxiety, and stress-related disorders (hazard ratio [HR], 0.88; 95% confidence interval [CI], 0.81 to 0.97), whereas the use of non-aspirin NSAIDs alone was associated with a higher rate (HR, 1.24; 95% CI, 1.15 to 1.32), after adjustment for sociodemographic factors, comorbidity, indications for NSAID use, and cancer characteristics. The association of aspirin with reduced rate of depression, anxiety, and stress-related disorders was strongest for current use (HR, 0.84; 95% CI, 0.75 to 0.93), low-dose use (HR, 0.88; 95% CI, 0.80 to 0.98), long-term use (HR, 0.84; 95% CI, 0.76 to 0.94), and among patients with cardiovascular disease (HR, 0.81; 95% CI, 0.68 to 0.95) or breast cancer (HR, 0.74; 95% CI, 0.56 to 0.98).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Pre-diagnostic use of aspirin was associated with a decreased risk of depression, anxiety, and stress-related disorders during the first year following cancer diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-020-01709-4","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T09:52:25Z","timestamp":1599731545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Aspirin and other non-steroidal anti-inflammatory drugs and depression, anxiety, and stress-related disorders following a cancer diagnosis: a nationwide register-based cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Kejia","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvid","family":"Sj\u00f6lander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam K.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica K.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Fall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unnur","family":"Valdimarsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin E.","family":"Smedby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"issue":"2","key":"1709_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","volume":"12","author":"AJ Mitchell","year":"2011","unstructured":"Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160\u201374.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1709_CR2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12885-018-4270-4","volume":"18","author":"J Zhu","year":"2018","unstructured":"Zhu J, Sj\u00f6lander A, Fall K, Valdimarsdottir U, Fang F. Mental disorders around cancer diagnosis and increased hospital admission rate - a nationwide cohort study of Swedish cancer patients. BMC Cancer. 2018;18(1):322.","journal-title":"BMC Cancer"},{"issue":"8","key":"1709_CR3","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/annonc\/mdx265","volume":"28","author":"J Zhu","year":"2017","unstructured":"Zhu J, Fang F, Sj\u00f6lander A, Fall K, Adami HO, Valdimarsd\u00f3ttir U. First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study. Ann Oncol. 2017;28(8):1964\u20139.","journal-title":"Ann Oncol"},{"key":"1709_CR4","doi-asserted-by":"publisher","first-page":"j108","DOI":"10.1136\/bmj.j108","volume":"356","author":"GD Batty","year":"2017","unstructured":"Batty GD, Russ TC, Stamatakis E, Kivim\u00e4ki M. Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies. BMJ. 2017;356:j108.","journal-title":"BMJ."},{"issue":"9","key":"1709_CR5","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1001\/jamaoncol.2016.0483","volume":"2","author":"D Lu","year":"2016","unstructured":"Lu D, Andersson TML, Fall K, Hultman CM, Czene K, Valdimarsd\u00f3ttir U, et al. Clinical diagnosis of mental disorders immediately before and after cancer diagnosis: a nationwide matched cohort study in Sweden. JAMA Oncol. 2016;2(9):1188\u201396.","journal-title":"JAMA Oncol"},{"issue":"6","key":"1709_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10865-012-9453-x","volume":"36","author":"JR Schumacher","year":"2013","unstructured":"Schumacher JR, Palta M, Loconte NK, Trentham-Dietz A, Witt WP, Heidrich SM, et al. Characterizing the psychological distress response before and after a cancer diagnosis. J Behav Med. 2013;36(6):591\u2013600.","journal-title":"J Behav Med"},{"issue":"1","key":"1709_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12885-017-3260-2","volume":"17","author":"GM Kim","year":"2017","unstructured":"Kim GM, Kim SJ, Song SK, Kim HR, Kang BD, Noh SH, et al. Prevalence and prognostic implications of psychological distress in patients with gastric cancer. BMC Cancer. 2017;17(1):283.","journal-title":"BMC Cancer"},{"issue":"7744","key":"1709_CR8","first-page":"460","volume":"340","author":"KJ McCaffery","year":"2010","unstructured":"McCaffery KJ, Irwig L, Turner R, Chan SF, Macaskill P, Lewicka M, et al. Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial. BMJ. 2010;340(7744):460.","journal-title":"BMJ."},{"issue":"5","key":"1709_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1200\/JCO.2016.68.5826","volume":"35","author":"MC Janelsins","year":"2017","unstructured":"Janelsins MC, Heckler CE, Peppone LJ, Kamen C, Mustian KM, Mohile SG, et al. Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study. J Clin Oncol. 2017;35(5):506\u201314.","journal-title":"J Clin Oncol"},{"issue":"21","key":"1709_CR10","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2017.76.4696","volume":"36","author":"KR Krull","year":"2018","unstructured":"Krull KR, Hardy KK, Kahalley LS, Schuitema I, Kesler SR. Neurocognitive outcomes and interventions in long-term survivors of childhood cancer. J Clin Oncol. 2018;36(21):2181\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1709_CR11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/JTO.0000000000000084","volume":"9","author":"M Jeantieu","year":"2014","unstructured":"Jeantieu M, Gaillat F, Antonini F, Azoulay E, Martin C, Thomas P, et al. Postoperative pain and subsequent ptsd-related symptoms in patients undergoing lung resection for suspected cancer. J Thorac Oncol. 2014;9(3):362\u20139.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"1709_CR12","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1038\/cti.2016.18","volume":"5","author":"T-H Kim","year":"2016","unstructured":"Kim T-H, Rowat AC, Sloan EK. Neural regulation of cancer: from mechanobiology to inflammation. Clin Transl Immunol. 2016;5(5):e78.","journal-title":"Clin Transl Immunol"},{"issue":"1","key":"1709_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27\u201341.","journal-title":"Immunity."},{"issue":"6917","key":"1709_CR14","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860\u20137.","journal-title":"Nature."},{"issue":"11","key":"1709_CR15","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493\u2013503.","journal-title":"Lancet Oncol."},{"issue":"1","key":"1709_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46\u201356.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"1709_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/wps.20723","volume":"19","author":"AH Miller","year":"2020","unstructured":"Miller AH. Beyond depression: the expanding role of inflammation in psychiatric disorders. World Psychiatry. 2020;19(1):108\u20139.","journal-title":"World Psychiatry"},{"issue":"4","key":"1709_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/da.22084","volume":"30","author":"AH Miller","year":"2013","unstructured":"Miller AH, Haroon E, Raison CL, Felger JC. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety. 2013;30(4):297\u2013306.","journal-title":"Depress Anxiety"},{"issue":"1","key":"1709_CR19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/npp.2016.146","volume":"42","author":"V Michopoulos","year":"2017","unstructured":"Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. Inflammation in fear-and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 2017;42(1):254\u201370.","journal-title":"Neuropsychopharmacology."},{"issue":"8\u201310","key":"1709_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.psyneuen.2007.07.001","volume":"32","author":"P Pervanidou","year":"2007","unstructured":"Pervanidou P, Kolaitis G, Charitaki S, Margeli A, Ferentinos S, Bakoula C, et al. Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident. Psychoneuroendocrinology. 2007;32(8\u201310):991\u20139.","journal-title":"Psychoneuroendocrinology."},{"issue":"5","key":"1709_CR21","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/annrheumdis-2018-214676","volume":"78","author":"A Dregan","year":"2019","unstructured":"Dregan A, Matcham F, Harber-Aschan L, Rayner L, Brailean A, Davis K, et al. Common mental disorders within chronic inflammatory disorders: a primary care database prospective investigation. Ann Rheum Dis. 2019;78(5):688\u201395.","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"1709_CR22","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1056\/NEJM199106133242407","volume":"324","author":"JA Oates","year":"1991","unstructured":"Oates JA, Wood AJJ, Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs \u2014 differences and similarities. N Engl J Med. 1991;324(24):1716\u201325.","journal-title":"N Engl J Med"},{"issue":"7","key":"1709_CR23","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3390\/ph3072146","volume":"3","author":"IL Meek","year":"2010","unstructured":"Meek IL, van de Laar MAFJ, Vonkeman HE. Non-steroidal anti-inflammatory drugs: an overview of cardiovascular risks. Pharmaceuticals. 2010;3(7):2146\u201362.","journal-title":"Pharmaceuticals."},{"issue":"1","key":"1709_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/jnnp-2019-320912","volume":"91","author":"S Bai","year":"2020","unstructured":"Bai S, Guo W, Feng Y, Deng H, Li G, Nie H, et al. Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry. 2020;91(1):21\u201332.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1709_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/acps.12957","volume":"139","author":"LV Kessing","year":"2019","unstructured":"Kessing LV, Rytgaard HC, Gerds TA, Berk M, Ekstr\u00f8m CT, Andersen PK. New drug candidates for depression - a nationwide population-based study. Acta Psychiatr Scand. 2019;139(1):68\u201377.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"1709_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1503\/jpn160244","volume":"42","author":"IK Wium-Andersen","year":"2017","unstructured":"Wium-Andersen IK, Wium-Andersen MK, J\u00f8rgensen MB, Osler M. Anti-inflammatory treatment and risk for depression after first-time stroke in a cohort of 147 487 Danish patients. J Psychiatry Neurosci. 2017;42(5):320\u201330.","journal-title":"J Psychiatry Neurosci"},{"issue":"11","key":"1709_CR27","doi-asserted-by":"publisher","first-page":"1017.e11","DOI":"10.1016\/j.amjmed.2013.02.037","volume":"126","author":"RL Iyengar","year":"2013","unstructured":"Iyengar RL, Gandhi S, Aneja A, Thorpe K, Razzouk L, Greenberg J, et al. NSAIDs are associated with lower depression scores in patients with osteoarthritis. Am J Med. 2013;126(11):1017.e11\u20138.","journal-title":"Am J Med"},{"issue":"12","key":"1709_CR28","doi-asserted-by":"publisher","first-page":"e0208593","DOI":"10.1371\/journal.pone.0208593","volume":"13","author":"AK Walker","year":"2018","unstructured":"Walker AK, Chang A, Ziegler AI, Dhillon HM, Vardy JL, Sloan EK. Low dose aspirin blocks breast cancer-induced cognitive impairment in mice. PLoS One. 2018;13(12):e0208593.","journal-title":"PLoS One"},{"issue":"1","key":"1709_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/02841860802247664","volume":"48","author":"L Barlow","year":"2009","unstructured":"Barlow L, Westergren K, Holmberg L, Talb\u00e4ck M. The completeness of the Swedish Cancer Register \u2013 a sample survey for year 1998. Acta Oncol (Madr). 2009;48(1):27\u201333.","journal-title":"Acta Oncol (Madr)"},{"key":"1709_CR30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"},{"issue":"7","key":"1709_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, MichaelFored C, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726\u201335.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"31","key":"1709_CR32","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1200\/JCO.2014.56.0086","volume":"32","author":"A Mehnert","year":"2014","unstructured":"Mehnert A, Br\u00e4hler E, Faller H, H\u00e4rter M, Keller M, Schulz H, et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol. 2014;32(31):3540\u20136.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1709_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000446991","volume":"85","author":"S Kuhnt","year":"2016","unstructured":"Kuhnt S, Br\u00e4hler E, Faller H, H\u00e4rter M, Keller M, Schulz H, et al. Twelve-month and lifetime prevalence of mental disorders in cancer patients. Psychother Psychosom. 2016;85(5):289\u201396.","journal-title":"Psychother Psychosom"},{"issue":"5","key":"1709_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1570159X15666171123201142","volume":"16","author":"JC Felger","year":"2018","unstructured":"Felger JC. Imaging the role of inflammation in mood and anxiety-related disorders. Curr Neuropharmacol. 2018;16(5):533\u201388.","journal-title":"Curr Neuropharmacol"},{"key":"1709_CR35","first-page":"73","volume-title":"Cancer data linkage in manitoba: expanding the infrastructure for research","author":"L Lix","year":"2016","unstructured":"Lix L, Ps MS, Pitz M, Rashid Ahmed F, Quon H, Griffith J, et al. Cancer data linkage in manitoba: expanding the infrastructure for research. Winnipeg: MB Manitoba Centre for Health Policy; 2016. p. 73\u20134."},{"issue":"2","key":"1709_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0895-4356(92)90016-G","volume":"45","author":"M Von Korff","year":"1992","unstructured":"Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45(2):197\u2013203.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"1709_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","volume":"34","author":"JF Ludvigsson","year":"2019","unstructured":"Ludvigsson JF, Svedberg P, Ol\u00e9n O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423\u201337.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"1709_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1741-7015-11-74","volume":"11","author":"M Berk","year":"2013","unstructured":"Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, O\u2019Neil A, et al. Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med. 2013;11(1):74.","journal-title":"BMC Med"},{"issue":"5","key":"1709_CR39","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1096\/fj.07-9411com","volume":"22","author":"SH Choi","year":"2008","unstructured":"Choi SH, Langenbach R, Bosetti F. Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury. FASEB J. 2008;22(5):1491\u2013501.","journal-title":"FASEB J"},{"issue":"1","key":"1709_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1742-2094-5-17","volume":"5","author":"S Aid","year":"2008","unstructured":"Aid S, Langenbach R, Bosetti F. Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2. J Neuroinflammation. 2008;5(1):17.","journal-title":"J Neuroinflammation"},{"issue":"11","key":"1709_CR41","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.4049\/jimmunol.0903816","volume":"184","author":"MM-Y Chan","year":"2010","unstructured":"Chan MM-Y, Moore AR. Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J Immunol. 2010;184(11):6418\u201326.","journal-title":"J Immunol"},{"issue":"23","key":"1709_CR42","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2165\/00003495-200464230-00001","volume":"64","author":"G Onder","year":"2004","unstructured":"Onder G, Pellicciotti F, Gambassi G, Bernabei R. NSAID-related psychiatric adverse events. Drugs. 2004;64(23):2619\u201327.","journal-title":"Drugs."},{"issue":"2","key":"1709_CR43","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1161\/01.ATV.0000196729.98651.bf","volume":"26","author":"N Chiang","year":"2006","unstructured":"Chiang N, Hurwitz S, Ridker PM, Serhan CN. Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: a randomized human trial. Arterioscler Thromb Vasc Biol. 2006;26(2):e14\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"26","key":"1709_CR44","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1200\/JCO.2011.36.1154","volume":"29","author":"JE Bower","year":"2011","unstructured":"Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol. 2011;29(26):3517\u201322.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1709_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13058-018-1065-0","volume":"20","author":"G Frisk","year":"2018","unstructured":"Frisk G, Ekberg S, Lidbrink E, Eloranta S, Sund M, Fredriksson I, et al. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study. Breast Cancer Res. 2018;20(1):142.","journal-title":"Breast Cancer Res"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01709-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-020-01709-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01709-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T20:34:50Z","timestamp":1650227690000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01709-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1709"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01709-4","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,9]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Regional Ethics Review Board in Stockholm, Sweden (Dnr 2015\/1574\u201331). No personal consent is needed from the register-based study participants, as the study involves no direct contact with the participants and all data were anonymized and non-identifiable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"It was not necessary to gain consent from individual participants for publication since anonymous data in such a way that the individual is no longer identifiable is not considered to be personal data, and thus not governed by the European Union General Data Protection Regulation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}